Your browser doesn't support javascript.
loading
[Preliminary study on the role of voltage-gated sodium channel subtype Nav1.5 in lymph node metastasis of oral squamous cell carcinoma].
Liu, W J; Xu, L; Zhu, X W; Chen, X F; Wang, H; Jiang, Y.
Afiliação
  • Liu WJ; Department of Stomatology, The Fourth Affiliated Hospital of Anhui Medical University, Hefei 230032, China.
  • Xu L; Department of Stomatology, The Fourth Affiliated Hospital of Anhui Medical University, Hefei 230032, China.
  • Zhu XW; Department of Stomatology, The Fourth Affiliated Hospital of Anhui Medical University, Hefei 230032, China.
  • Chen XF; Department of Stomatology, The Fourth Affiliated Hospital of Anhui Medical University, Hefei 230032, China.
  • Wang H; Department of Stomatology, The Fourth Affiliated Hospital of Anhui Medical University, Hefei 230032, China.
  • Jiang Y; Department of Stomatology, The Fourth Affiliated Hospital of Anhui Medical University, Hefei 230032, China.
Zhonghua Kou Qiang Yi Xue Za Zhi ; 52(3): 188-193, 2017 Mar 09.
Article em Zh | MEDLINE | ID: mdl-28279058
ABSTRACT

Objective:

To investigate the relationship between the expression of voltage-gated sodium channel subtype Nav1.5 in oral squamous cell carcinoma (OSCC) and the occurrence and lymph node metastasis of OSCC.

Methods:

Totally 10 samples of normal oral mucosa tissue as control group, 26 samples of OSCC as the experimental group was divided into non-metastatic group (n=16) and metastatic group (n=10) according to the presence or absence of lymph node metastasis. Quantitative real-time PCR (qPCR), Western blotting, immunohistochemistry, and enzyme-linked immunosorbent assay (ELISA) were used to detect the expression of Nav1.5 in control group and experimental groups at mRNA and protein levels. The data were analyzed by one-way analysis.

Results:

The expression of Nav1.5 mRNA in the experimental group (non-metastatic group 2.311±0.134, metastatic group 4.462±0.362) was higher than those in the control group (1.054±0.162) (P=0.037; P=0.029), and the metastasis group was significantly higher than the non-metastasis group (P=0.031). Western blotting showed the expression of Nav1.5 in experimental groups (non-metastatic 0.143±0.005, metastatic 0.253±0.015) was up-regulated significantly compared with control group (0.080±0.010) (P=0.034, P=0.026), and the metastasis group was significantly higher than the non-metastasis group (P=0.033). The immunohistochemistry show the positive expression rates of Nav1.5 in normal and OSCC tissues were 1/10 and 92% (24/26). The differences were statistically significant (P=0.016), and the metastasis group was significantly higher than the non-metastasis group (P=0.028). The ELISA results revealed that the level of Nav1.5 in control was control group (0.834±0.103) µg/L, in non-metastasis group was (1.578±0.167) µg/L, in metastasis group was (3.882±0.422) µg/L (P=0.041; P=0.032), and the metastasis group was significantly higher than the non-metastasis group (P=0.030).

Conclusions:

Nav1.5 was highly expressed in poorly differentiated OSCC and the expression was significantly different with or without lymph node metastasis. Nav1.5 may be involved in the occurrence and metastasis of OSCC.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Bucais / Carcinoma de Células Escamosas / Canal de Sódio Disparado por Voltagem NAV1.5 Tipo de estudo: Observational_studies Limite: Female / Humans / Male Idioma: Zh Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Bucais / Carcinoma de Células Escamosas / Canal de Sódio Disparado por Voltagem NAV1.5 Tipo de estudo: Observational_studies Limite: Female / Humans / Male Idioma: Zh Ano de publicação: 2017 Tipo de documento: Article